-transparent.png){kind=logo}
Obinutuzumab, a potent anti-B-cell agent, for rituximab-unresponsive IgM anti-MAG neuropathy. 2018
Department of Neurology (G.R., M.C.D.), Department of Hematology (U.M.-O.), Thomas Jefferson University, Philadelphia, PA; and Neuroimmunology Unit (M.C.D.), Department of Pathophysiology, Faculty of Medicine, National and Kapodistrian University of Athens, Greece.
| UI | MeSH Term | Description | Entries |
|---|
Related Publications
Goran Rakocevic, and
Ubaldo Martinez-Outschoorn, and
Marinos C Dalakas
January 1996,
Annales de medecine interne,
Goran Rakocevic, and
Ubaldo Martinez-Outschoorn, and
Marinos C Dalakas
November 2020,
Blood,
Goran Rakocevic, and
Ubaldo Martinez-Outschoorn, and
Marinos C Dalakas
September 2005,
Muscle & nerve,
Goran Rakocevic, and
Ubaldo Martinez-Outschoorn, and
Marinos C Dalakas
June 2015,
Annals of hematology,
Goran Rakocevic, and
Ubaldo Martinez-Outschoorn, and
Marinos C Dalakas
June 2013,
Journal of the peripheral nervous system : JPNS,
Goran Rakocevic, and
Ubaldo Martinez-Outschoorn, and
Marinos C Dalakas
November 2011,
Journal of neurology, neurosurgery, and psychiatry,
Goran Rakocevic, and
Ubaldo Martinez-Outschoorn, and
Marinos C Dalakas
July 1988,
Annals of neurology,
Goran Rakocevic, and
Ubaldo Martinez-Outschoorn, and
Marinos C Dalakas
February 2017,
Journal of the neurological sciences,
Goran Rakocevic, and
Ubaldo Martinez-Outschoorn, and
Marinos C Dalakas
June 2017,
Journal of the neurological sciences,
Goran Rakocevic, and
Ubaldo Martinez-Outschoorn, and
Marinos C Dalakas
August 1992,
Muscle & nerve,
